Top Market News

Centre may seek legal opinion on sterile drug licensing after SC ruling 1 hr ago
The Centre is considering seeking a legal opinion on sterile drug licensing following a Supreme Court ruling. The development signals a potential review of the regulatory framework for sterile drug manufacturing in India. Sterile drugs, including injectables, are subject to stringent licensing requirements under India's pharmaceutical regulations. The legal opinion, if sought, would guide the government's next steps in aligning licensing practices with the court's ruling.
no imag found
no imag found
Divi's Labs, TVS Motor emerge as Nifty 50 inclusion contenders 1 hr ago
no imag found
India 10-year bond yield rises to 7.2135% from 7.2108% previous close 1 hr ago
no imag found
Trump says lack of refineries is the problem 9 hrs ago
no imag found
Brent crude futures settle 1.89% lower at $100.32 per barrel 9 hrs ago
no imag found
US crude oil futures settle 1.84% lower at $89.43 per barrel 9 hrs ago

Today's Top Gainers

Trent
2,855.70
(+10.69%)
BSE
3,266.40
(+2.73%)
Maruti Suzuki
11,576.00
(+0.38%)
Interglobe Aviation
4,958.60
(+0.48%)
Hindustan Unilever
1,859.20
(+1.13%)

Today's Top Losers

Apollo Hospitals
7,888.00
(-1.21%)
Tech Mahindra
1,511.80
(-1.57%)
Titan
4,563.10
(-0.37%)
Eicher Motors
7,010.00
(-0.16%)

Today's Top Gainers

Trent
2,855.70
(+10.69%)
BSE
3,266.40
(+2.73%)
Maruti Suzuki
11,576.00
(+0.38%)
Interglobe Aviation
4,958.60
(+0.48%)
Hindustan Unilever
1,859.20
(+1.13%)

Today's Top Losers

Apollo Hospitals
7,888.00
(-1.21%)
Tech Mahindra
1,511.80
(-1.57%)
Titan
4,563.10
(-0.37%)
Eicher Motors
7,010.00
(-0.16%)
Must Read Next
SRIT India lists at ₹148 on NSE, above issue price of ₹130 10 mins ago
no imag found
Shah Investors Home shares list at ₹171, above ₹167 issue price 10 mins ago
Orient Cables lists at ₹448.1 on BSE, a premium to IPO price of ₹272 1 day ago